ASX
Imugene Limited
IMU:ASX•Healthcare
Sensitive ASX Announcement
FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
Published: 10/08/22, 09:18am (AEST)•3 pages